IPO
Regenlab USA Inc.
Filed with the SEC to go public on Sep 25, 2026. Newest amendment Oct 27, 2026.
Terms
| Price range | US$6.00 to US$8.00 a share | |
| Shares offered | 2,500,000 shares of common stock | |
| Offering size | US$15 million to US$20 million | Shares offered times the price range, worked out by 6ix |
| Listing | RGNA on Nasdaq | Has applied to list |
From the cover of the amended prospectus (S-1/A) filed Oct 27, 2026
Steps
| Draft sent to the SEC in confidence | Oct 20, 2025 |
| Filed publicly | Sep 25, 2026 |
| Amended once | Oct 27, 2026 |
| Shares registered with an exchange | Not yet |
| Declared effective by the SEC | Not yet |
| Final prospectus, with the price | Not yet |
Filings
- Oct 28, 2026 FWP · Free writing prospectus
- Oct 27, 2026 S-1/A · Registration statement, amended
- Sep 25, 2026 S-1 · Registration statement
- Jun 16, 2026 DRS/A · Draft registration statement, amended
- May 14, 2026 DRS/A · Draft registration statement, amended
- Jan 30, 2026 DRS/A · Draft registration statement, amended
- Oct 20, 2025 DRS · Draft registration statement